In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Apax buys operating divisions of Spanish generics company Invent

Executive Summary

Spanish generics company Invent Farma SL's three operating subsidiaries (Inke SA, Lesvi SL, and Qualigen SL) were acquired by funds advised by PE firm Apax Partners from Invent founder/owner Silfurberg (an investment company of the Fridrik Steinn Kristjansson family) and a consortium of Invent investors that included PE funds Framtakssjoour Islands (Enterprise Investment Fund) and Horn II.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Buy-out
    • Full Acquisition

Related Companies